- Home
- » Tags
- » Evergreening
Top View
- Harvard Journal of Law & Technology Volume 33, Number 2 Spring 2020
- I Think, Therefore I Invent: Creative Computers and the Future of Patent Law Ryan Abbott University of Surrey School of Law, [email protected]
- 6.2. Are Zombie Firms Curbing the Growth of Viable Firms?
- Innovation, Intellectual Property, and Development
- Economics of Intellectual Property
- REVIEW of EXISTING RESEARCH on PATENTS and ACCESS to MEDICAL PRODUCTS and HEALTH TECHNOLOGIES Prepared by the Secretariat
- 3(D) View of India's Patent Law: Social Justice Aspiration Meets Property
- Does a Large Loss of Bank Capital Cause Evergreening? Evidence from Japan
- Patents ECOSOC Background Guide
- MANIFESTO for HAPPINESS Shifting Society from Money to Well-Being
- Evergreening" Metaphor in Intellectual Property Scholarship
- A Critical Discourse Analysis of the Intellectual Property Chapter of The
- AMENDMENT on the PHARMACEUTICAL INDUSTRY and ACCESS to MEDICINES in INDIA Subhajit Banerji and Anagh Sengupta*
- 191 Robert D. Cooter* & Uri Y. Hacohen† 22 YALE J.L. & T ECH. 191 (2020) the U.S. Constitution Authorizes Congress To
- Product Market Regulation, Business Churning and Productivity: Evidence from the European Union Countries
- Solving the Problem of New Uses Draft 10/14/16
- Creative Destruction and Strategic Protection: Evidence from Pharmaceutical Patenting
- Ever-Greening in Pharmaceuticals
- Pharmaceutical Policy in the United States in 2019: an Overview of the Landscape and a Venues for Improvement
- A New Era of Queer Politics? Prep, Foucauldian Sexual Liberation, and the Overcoming of Homonormativity1
- Angus King: Rethinking Free Trade
- Patent “Evergreening”: Issues in Innovation and Competition
- Working Within the Trips Agreement Flexibilities to Provide Pharmaceutical Patent Protection While Protecting Public Health
- Competition and Antitrust Issues in the Pharmaceutical Industry
- Rethinking Trade Treaties & Access to Medicines
- HIV/AIDS, 'TRIPS-Plus' and 'Knowledge Ecology'
- Zombie Companies in China: Policies of Creative
- A Global Perspective on Patents and Evergreening: Lessons for South Africa As A
- Compulsory Licensing and Anti-Evergreening: Interpreting the TRIPS Flexibilities in Sections 84 and 3(D) of the Indian Patents Act
- 1. the Health Impact Fund: a Summary Overview
- Novcember 18' Pharma Aff
- Power, Capital, and the Social Structure of Accumulation in the Hashemite Kingdom of Jordan [Book in Draft]
- The Chinese Experience with Pharmaceutical Patent Linkage
- The Global Regime of Intellectual Property Rights
- Market Power and Inequality: the Revenge of the Rentiers
- GSK Public Policy Positions
- Ip Strategies and Policies for and Against Evergreening
- November 5, 2019 Director of the U.S. Patent and Trademark Office P.O